APA (7th ed.) Citation

A, S., M, N., M, D., K, A. S., B, A., JA, E., . . . Ö, K. (2019). Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 44(4), 639. https://doi.org/10.1111/coa.13316

Chicago Style (17th ed.) Citation

A, Sukari, Nagasaka M, Diab M, Al Sibai K, Atassi B, Elayoubi JA, Kim S, and Küçük Ö. "Cetuximab and Methotrexate in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma-A Single Institution Analysis of 54 Patients." Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 44, no. 4 (2019): 639. https://doi.org/10.1111/coa.13316.

MLA (9th ed.) Citation

A, Sukari, et al. "Cetuximab and Methotrexate in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma-A Single Institution Analysis of 54 Patients." Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, vol. 44, no. 4, 2019, p. 639, https://doi.org/10.1111/coa.13316.